摘要
这篇综述提出和讨论了利什曼病治疗的现状和远景,重点侧重在蛋白抑制剂的使用。提出和讨论了治疗发展的历史,第一代,第二代现代药物和使用蛋白酶抑制剂治疗利什曼病的优点和缺点。这篇报道证实了蛋白酶抑制剂作为现代利什曼病治疗的一种可替代或者补充疗法的潜在有用性。他们也支持了用多种蛋白酶抑制剂联合治疗可能对脊椎动物宿主中对抗利士曼原虫感染是有效的的这种假说。
关键词: 利什曼病,利什曼虫,蛋白酶,蛋白酶抑制剂,治疗,致病因子
Current Drug Targets
Title:Proteinase Inhibitors: A Promising Drug Class for Treating Leishmaniasis
Volume: 15 Issue: 12
Author(s): Bernardo Acacio Santini Pereira, Franklin Souza-Silva, Mariana Silva-Almeida, Raquel Santos-de-Souza, Luiz Filipe Goncalves de Oliveira, Michelle Lopes Ribeiro-Guimaraes and Carlos Roberto Alves
Affiliation:
关键词: 利什曼病,利什曼虫,蛋白酶,蛋白酶抑制剂,治疗,致病因子
摘要: This review presents and discusses the current status and perspectives of leishmaniasis treatment, with a special focus on the use of proteinase inhibitors. The history of treatment development, the first- and second-choice modern drugs and the advantages and disadvantages of using proteinases inhibitors as leishmanicidal treatments are presented and discussed. The reports gathered herein confirm the potential usefulness of proteinases inhibitors as an alternative or complement to the current leishmaniasis treatments. They also support the hypothesis that a combined treatment with multiple proteinase inhibitors may be efficient against Leishmania infections in vertebrate hosts.
Export Options
About this article
Cite this article as:
Pereira Acacio Santini Bernardo, Souza-Silva Franklin, Silva-Almeida Mariana, Santos-de-Souza Raquel, Oliveira Filipe Goncalves de Luiz, Ribeiro-Guimaraes Lopes Michelle and Alves Roberto Carlos, Proteinase Inhibitors: A Promising Drug Class for Treating Leishmaniasis, Current Drug Targets 2014; 15 (12) . https://dx.doi.org/10.2174/1389450115666141016150007
DOI https://dx.doi.org/10.2174/1389450115666141016150007 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Journals
Related Books
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Importance of Alkynyl Chain Presence for the Activity of Adenine Nucleosides/Nucleotides on Purinergic Receptors
Current Medicinal Chemistry Nebulizer Therapy in Pulmonology: Review of the Literature
Current Respiratory Medicine Reviews Clinical and Pharmacological Aspects of Inflammatory Demyelinating Diseases in Childhood: An Update
Current Neuropharmacology Anti-Inflammatory Effects of Intravenous Anesthetics on Endotoxemia
Mini-Reviews in Medicinal Chemistry Polyphenols: A Nutraceutical Approach Against Diseases
Recent Patents on Food, Nutrition & Agriculture Targeting Trypanosoma cruzi Platelet-activating Factor Receptors: Scope for the Development of Novel Drugs to Treat Chagas Disease
Mini-Reviews in Medicinal Chemistry Age-Related Pharmacokinetic and Pharmacodynamic Changes and Related Risk of Adverse Drug Reactions
Current Medicinal Chemistry Antibody Recognition of Fluorinated Haptens and Antigens
Current Topics in Medicinal Chemistry Renal and Urological Diseases of the Newborn Neonatal Acute Kidney Injury
Current Pediatric Reviews The Effect of Serotonin 5-HT2 Receptor Inhibitor on Vasomotor Responses
Vascular Disease Prevention (Discontinued) Anthracyclines Still Prove Effective in Anticancer Therapy
Mini-Reviews in Medicinal Chemistry The Role of Niacin in Lipid-lowering Treatment: Are we Aiming Too High?
Current Pharmaceutical Design Pulmonary Hypertension: Types and Treatments
Current Cardiology Reviews Clonidine in Perioperative Medicine and Intensive Care Unit: More Than An Anti-Hypertensive Drug
Current Drug Targets The Vasoactive Role of Nitric Oxide: Physiological and Morphological Aspects
Current Pharmaceutical Biotechnology The Medical Complications of Anorexia Nervosa and Their Treatments
Current Women`s Health Reviews Acute Stroke Therapy: Combination Drugs and Multifunctional Neuroprotectants
Current Neuropharmacology Hypersensitivity Reactions to Last Generation Chimeric, Umanized and Human Recombinant Monoclonal Antibodies for Therapeutic Use
Current Pharmaceutical Design Atrial Tachycardias Occurring Late After Open Heart Surgery
Current Cardiology Reviews COVID-19 Invades Several Important Organs other than the Lungs: Organs Crosstalk
Coronaviruses